中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Illudalic acid as a potential LAR inhibitor: Synthesis, SAR, and preliminary studies on the mechanism of action

文献类型:期刊论文

作者Ling, Qing2; Huang, Yue2; Zhou, Yueyang1; Cai, Zhengliang2; Xiong, Bing2; Zhang, Yahui1; Ma, Lanping2; Wang, Xin2; Li, Xin2; Li, Jia1
刊名BIOORGANIC & MEDICINAL CHEMISTRY
出版日期2008-08-01
卷号16期号:15页码:7399-7409
关键词human leukocyte common antigen-related phosphatase (LAR) illudalic acid inhibitor mechanism structure-activity relationship (SAR) synthesis
ISSN号0968-0896
DOI10.1016/j.bmc.2008.06.014
文献子类Article
英文摘要A novel synthesis of the human leukocyte common antigen-related (LAR) phosphatase inhibitor, illudalic acid, has been achieved by a route more amenable to structure modi. cations. A series of simpler analogues of illudalic acid was synthesized and evaluated for potency in inhibiting LAR. The structure -activity relationship (SAR) study has shown that the 5-formyl group and the hemi-acetal lactone are crucial for effective inhibition of LAR activity, and are the key pharmacophores of illudalic acid. The fused dimethylcyclopentene ring moiety evidently helps to enhance the potency of illudalic acid against LAR. A preliminary study of the mechanism of action of illudalic acid against LAR was conducted using electrospray ionization mass spectrometry (ESI-MS) and molecular docking techniques. The results are in full agreement with the described mechanism. (C) 2008 Elsevier Ltd. All rights reserved.
WOS关键词PROTEIN-TYROSINE PHOSPHATASES ; LEUKOCYTE-COMMON ANTIGEN ; STRUCTURE-BASED DESIGN ; 1B INHIBITORS ; ALLOSTERIC-INHIBITION ; MASS-SPECTROMETRY ; PTP1B INHIBITORS ; INSULIN-RECEPTOR ; DISCOVERY ; BETA
资助项目Hi-Tech Research and Development Program of China[2006AA02Z315] ; Hi-tech Research and Development Program of China[2007AA09Z402]
WOS研究方向Biochemistry & Molecular Biology ; Pharmacology & Pharmacy ; Chemistry
语种英语
WOS记录号WOS:000258749500034
出版者PERGAMON-ELSEVIER SCIENCE LTD
源URL[http://119.78.100.183/handle/2S10ELR8/272847]  
专题国家新药筛选中心
中科院受体结构与功能重点实验室
新药研究国家重点实验室
药物化学研究室
通讯作者Li, Jia
作者单位1.Natl Ctr Drug Screening, Shanghai 201203, Peoples R China;
2.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China
推荐引用方式
GB/T 7714
Ling, Qing,Huang, Yue,Zhou, Yueyang,et al. Illudalic acid as a potential LAR inhibitor: Synthesis, SAR, and preliminary studies on the mechanism of action[J]. BIOORGANIC & MEDICINAL CHEMISTRY,2008,16(15):7399-7409.
APA Ling, Qing.,Huang, Yue.,Zhou, Yueyang.,Cai, Zhengliang.,Xiong, Bing.,...&Shen, Jingkang.(2008).Illudalic acid as a potential LAR inhibitor: Synthesis, SAR, and preliminary studies on the mechanism of action.BIOORGANIC & MEDICINAL CHEMISTRY,16(15),7399-7409.
MLA Ling, Qing,et al."Illudalic acid as a potential LAR inhibitor: Synthesis, SAR, and preliminary studies on the mechanism of action".BIOORGANIC & MEDICINAL CHEMISTRY 16.15(2008):7399-7409.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。